Nerve growth factor and the vanilloid receptor: Partners in crime?

Clinical and Experimental Allergy

Volumn 34, Issue 7, 2004, Pages 996-1000

  Van Den Worm, E ^a   Nijkamp, F P ^a   Engels, F ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY; NEUROTROPHIC FACTOR; TACHYKININ RECEPTOR ANTAGONIST; VANILLOID RECEPTOR;

ALLERGIC ASTHMA; BRONCHUS HYPERREACTIVITY; CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ASTHMA; BRONCHI; BRONCHIAL HYPERREACTIVITY; HUMANS; HYPERSENSITIVITY; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; RECEPTORS, DRUG;

EID: 3242761327     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02012.x     Document Type: Conference Paper

References (80)

1. Ibanez CF. Emerging themes in structural biology of neurotrophic factors. Trends Neurosci 1998; 21:438-44.
2. Renz H. Neurotrophins in bronchial asthma. Respir Res 2001; 2:265-8.
3. Amann R, Egger T, Schuligoi R. The tachykinin NK(1) receptor antagonist SR140333 prevents the increase of nerve growth factor in rat paw skin induced by substance P or neurogenic inflammation. Neuroscience 2000; 100:611-5.
4. Barnes PJ. Neurogenic inflammation in airways. Int Arch Allergy Appl Immunol 1991; 94:303-9.
5. Baluk P. Neurogenic inflammation in skin and airways. J Investig Dermatol Symp Proc 1997; 2:76-81.
6. Campbell EA, Gentry CT, Patel S, Panesar MS, Walpole CS, Urban L. Selective neurokinin-1 receptor antagonists are antihyperalgesic in a model of neuropathic pain in the guinea-pig. Neuroscience 1998; 87:527-32.
7. Cohen S. A nerve growth-stimulating factor isolated from sarcomas 37 and 180. Zoology 1954; 40:1014-8.
8. Hamburger V, Levi-Montalcini R. Proliferation, differentiation and degeneration in the spinal ganglia of the chick embryo under normal and experimental conditions. J Exp Zool 1949; 111:457-502.
9. Wiesmann C, Ultsch MH, Bass SH, de Vos AM. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 1999; 401:184-8.
10. Shao N, Wang H, Zhou T, Liu C. 7S nerve growth factor has different biological activity from 2.5S nerve growth factor in vitro. Brain Res 1993; 609:338-40.
11. Silverman RE, Bradshaw RA. Nerve growth factor: subunit interactions in the mouse submaxillary gland 7S complex. J Neurosci Res 1982; 8:127-36.
12. Kaplan DR, Hempstead BL, Martin-Zanca D, Chao MV, Parada LF. The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science 1991; 252:554-8.
13. Vedder H, Affolter HU, Otten U. Nerve growth factor (NGF) regulates tachykinin gene expression and biosynthesis in rat sensory neurons during early postnatal development. Neuropeptides 1993; 24:351-7.
14. Lindsay RM, Harmar AJ. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature 1989; 337:362-4.
15. Knipper M, Beck A, Rylett J, Breer H. Neurotrophin induced second messenger responses in rat brain synaptosomes. Neuroreport 1993; 4:483-6.
16. Woolf CJ, Ma QP, Allchorne A, Poole S. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation. J Neurosci 1996; 16:2716-23.
17. Braun A, Lommatzsch M, Renz H. The role of neurotrophins in allergic bronchial asthma. Clin Exp Allergy 2000; 30:178-86.
18. Leon A, Buriani A, Dal Toso R et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994; 91:3739-43.
19. Hattori A, Iwasaki S, Murase K et al. Tumor necrosis factor is markedly synergistic with interleukin 1 and interferon-gamma in stimulating the production of nerve growth factor in fibroblasts. FEBS Lett 1994; 340:177-80.
20. Mizuma H, Takagi K, Miyake K et al. Microsphere embolism-induced elevation of nerve growth factor level and appearance of nerve growth factor immunoreactivity in activated T-lymphocytes in the rat brain. J Neurosci Res 1999; 55:749-61.
21. Lambiase A, Bracci-Laudiero L, Bonini S et al. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J Allergy Clin Immunol 1997; 100:408-14.
22. Barouch R, Appel E, Kazimirsky G, Braun A, Renz H, Brodie C. Differential regulation of neurotrophin expression by mitogens and neurotransmitters in mouse lymphocytes. J Neuroimmunol 2000; 103:112-21.
23. Solomon A, Aloe L, Pe'er J, Frucht-Pery J, Bonini S, Levi-Schaffer F. Nerve growth factor is preformed in and activates human peripheral blood eosinophils. J Allergy Clin Immunol 1998; 102:454-60.
24. Fox AJ, Patel HJ, Barnes PJ, Belvisi MG. Release of nerve growth factor by human pulmonary epithelial cells: role in airway inflammatory diseases. Eur J Pharmacol 2001; 424:159-62.
25. Yoshida K, Kakihana M, Chen LS, Ong M, Baird A, Gage FH. Cytokine regulation of nerve growth factor-mediated cholinergic neurotrophic activity synthesized by astrocytes and fibroblasts. J Neurochem 1992; 59:919-31.
26. Burgi B, Otten UH, Ochensberger B et al. Basophil priming by neurotrophic factors. Activation through the trk receptor. J Immunol 1996; 157:5582-8.
27. Tal M, Liberman R. Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci Lett 1997; 221:129-32.
28. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989; 86:10059-63.
29. Susaki Y, Shimizu S, Katakura K et al. Functional properties of murine macrophages promoted by nerve growth factor. Blood 1996; 88:4630-7.
30. Lad SP, Neet KE, Mufson EJ. Nerve growth factor: structure, function and therapeutic implications for Alzheimer's disease. Curr Drug Target CNS Neurol Disord 2003; 2:315-34.
31. Treanor JJ, Dawbarn D, Allen SJ, MacGowan SH, Wilcock GK. Low affinity nerve growth factor receptor binding in normal and Alzheimer's disease basal forebrain. Neurosci Lett 1991; 121:73-6.
32. Allen SJ, MacGowan SH, Treanor JJ, Feeney R, Wilcock GK, Dawbarn D. Normal beta-NGF content in Alzheimer's disease cerebral cortex and hippocampus. Neurosci Lett 1991; 131:135-9.
33. Bevan S, Szolcsanyi J. Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol Sci 1990; 11:330-3.
34. Virchow JC, Julius P, Lommatzsch M, Luttmann W, Renz H, Braun A. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med 1998; 158:2002-5.
35. Bonini S, Lambiase A, Angelucci F, Magrini L, Manni L, Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc Natl Acad Sci USA 1996; 93:10955-60.
36. Sanico AM, Stanisz AM, Gleeson TD et al. Nerve growth factor expression and release in allergic inflammatory disease of the upper airways. Am J Respir Crit Care Med 2000; 161:1631-5.
37. Braun A, Appel E, Baruch R et al. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998; 28:3240-51.
38. Braun A, Quarcoo D, Schulte-Herbruggen O, Lommatzsch M, Hoyle G, Renz H. Nerve growth factor induces airway hyperresponsiveness in mice. Int Arch Allergy Immunol 2001; 124:205-7.
39. De Vries A, Engels F, Henricks PA, Leusink-Muis T, Fischer A, Nijkamp FP. Antibodies directed against nerve growth factor inhibit the acute bronchoconstriction due to allergen challenge in guinea-pigs. Clin Exp Allergy 2002; 32:325-8.
40. de Vries A, van Rijnsoever C, Engels F, Henricks PA, Nijkamp FP. The role of sensory nerve endings in nerve growth factor-induced airway hyperresponsiveness to histamine in guinea-pigs. Br J Pharmacol 2001; 134:771-6.
41. de Vries A, Dessing MC, Engels F, Henricks PA, Nijkamp FP. Nerve growth factor induces a neurokinin-1 receptor-mediated airway hyperresponsiveness in guinea pigs. Am J Respir Crit Care Med 1999; 159 (Part 5):1541-4.
42. Bachar O, Adner M, Uddman R, Cardell LO. Nerve growth factor enhances cholinergic innervation and contractile response to electric field stimulation in a murine in-vitro model of chronic asthma. Clin Exp Allergy 2004; 34:1137-45.
43. LeMaster AM, Krimm RF, Davis BM et al. Overexpression of brain-derived neurotrophic factor enhances sensory innervation and selectively increases neuron number. J Neurosci 1999; 19:5919-31.
44. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol Rev 1999; 51:159-212.
45. Di Marzo V, Blumberg PM, Szallasi A. Endovanilloid signaling in pain. Curr Opin Neurobiol 2002; 12:372-9.
46. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001; 24:487-517.
47. Oh U, Hwang SW, Kim D. Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons. J Neurosci 1996; 16:1659-67.
48. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997; 389:816-24.
49. Tominaga M, Caterina MJ, Malmberg AB et al. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 1998; 21:531-43.
50. Benham CD, Gunthorpe MJ, Davis JB. TRPV channels as temperature sensors. Cell Calcium 2003; 33:479-87.
51. Xu H, Ramsey IS, Kotecha SA et al. TRPV3 is a calcium-permeable temperature-sensitive cation channel. Nature 2002; 418:181-6.
52. Szallasi A. Autoradiographic visualization and pharmacological characterization of vanilloid (capsaicin) receptors in several species, including man. Acta Physiol Scand Suppl 1995; 629:1-68.
53. Biro T, Maurer M, Modarres S et al. Characterization of functional vanilloid receptors expressed by mast cells. Blood 1998; 91:1332-40.
54. Partsch G, Matucci-Cerinic M. Capsaicin stimulates the migration of human polymorphonuclear cells (PMN) in vitro. Life Sci 1993; 53:PL309-14.
55. Lai JP, Douglas SD, Ho WZ. Human lymphocytes express substance P and its receptor. J Neuroimmunol 1998; 86:80-6.
56. Lundberg JM, Martling CR, Saria A. Substance P and capsaicin-induced contraction of human bronchi. Acta Physiol Scand 1983; 119:49-53.
57. Chitano P, Di Blasi P, Lucchini RE et al. The effects of toluene diisocyanate and of capsaicin on human bronchial smooth muscle in vitro. Eur J Pharmacol 1994; 270:167-73.
58. Ellis JL, Sham JS, Undem BJ. Tachykinin-independent effects of capsaicin on smooth muscle in human isolated bronchi. Am J Respir Crit Care Med 1997; 155:751-5.
59. Szallasi A, Goso C, Manzini S. Resiniferatoxin binding to vanilloid receptors in guinea pig and human airways. Am J Respir Crit Care Med 1995; 152:59-63.
60. Marsh SJ, Stansfeld CE, Brown DA, Davey R, McCarthy D. The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro. Neuroscience 1987; 23:275-89.
61. Wood JN, Winter J, James IF, Rang HP, Yeats J, Bevan S. Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J Neurosci 1988; 8:3208-20.
62. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988; 24:739-68.
63. Saria A, Martling CR, Theodorsson-Norheim E, Gamse R, Hua XY, Lundberg JM. Coexisting peptides in capsaicin-sensitive sensory neurons: release and actions in the respiratory tract of the guinea-pig. Acta Physiol Hung 1987; 69:421-4.
64. Doherty MJ, Mister R, Pearson MG, Calverley PM. Capsaicin responsiveness and cough in asthma and chronic obstructive pulmonary disease. Thorax 2000; 55:643-9.
65. Choudry NB, Fuller RW. Sensitivity of the cough reflex in patients with chronic cough. Eur Respir J 1992; 5:296-300.
66. Kress M, Reeh PW, Vyklicky L. An interaction of inflammatory mediators and protons in small diameter dorsal root ganglion neurons of the rat. Neurosci Lett 1997; 224:37-40.
67. Vyklicky L, Knotkova-Urbancova H, Vitaskova Z, Vlachova V, Kress M, Reeh PW. Inflammatory mediators at acidic pH activate capsaicin receptors in cultured sensory neurons from newborn rats. J Neurophysiol 1998; 79:670-6.
68. Levi-Montalcini R, Angeletti P. Nerve growth factor. Physiol Rev 1968; 48:534-69.
69. Winter J, Forbes CA, Sternberg J, Lindsay RM. Nerve growth factor (NGF) regulates adult rat cultured dorsal root ganglion neuron responses to the excitotoxin capsaicin. Neuron 1988; 1:973-81.
70. Bevan S, Winter J. Nerve growth factor (NGF) differentially regulates the chemosensitivity of adult rat cultured sensory neurons. J Neurosci 1995; 15 (Part 1):4918-26.
71. Winston J, Toma H, Shenoy M, Pasricha PJ. Nerve growth factor regulates VR-1 mRNA levels in cultures of adult dorsal root ganglion neurons. Pain 2001; 89:181-6.
72. Nicholas RS, Winter J, Wren P, Bergmann R, Woolf CJ. Peripheral inflammation increases the capsaicin sensitivity of dorsal root ganglion neurons in a nerve growth factor-dependent manner. Neuroscience 1999; 91:1425-33.
73. Di Marzo V, De Petrocellis L, Sepe N, Buono A. Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem J 1996; 316 (Part 3):977-84.
74. Mechoulam R, Fride E, Di Marzo V. Endocannabinoids. Eur J Pharmacol 1998; 359:1-18.
75. Zygmunt PM, Petersson J, Andersson DA et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400:452-7.
76. Smart D, Gunthorpe MJ, Jerman JC et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 2000; 129:227-30.
77. Maccarrone M, Lorenzon T, Bari M, Melino G, Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J Biol Chem 2000; 275:31938-45.
78. Hwang SW, Cho H, Kwak J et al. Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances. Proc Natl Acad Sci USA 2000; 97:6155-60.
79. Folkerts G, Nijkamp FP, van Oosterhout AJ. Induction in guinea-pigs of airway hyperreactivity and decreased lung beta-adrenoceptor number by 15-hydroperoxy-arachidonic acid. Br J Pharmacol 1983; 80:597-9.
80. Engels F, van Houwelingen AH, Buckley TL, van de Velde MJ, Henricks PA, Nijkamp FP. Airway hyperresponsiveness induced by 13-hydroxyoctadecadienoic acid (13-HODE) is mediated by sensory neuropeptides. Adv Prostaglandin Thromboxane Leukot Res 1995; 23:361-3.